Perspective

Medical Innovation Versus Stem Cell Tourism

See allHide authors and affiliations

Science  26 Jun 2009:
Vol. 324, Issue 5935, pp. 1664-1665
DOI: 10.1126/science.1171749

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Stem cell tourism is criticized on grounds of consumer fraud, blatant lack of scientific justification, and patient safety. However, the issues are complex because they invoke questions concerning the limits of acceptable medical innovation and medical travel. Here we discuss these issues and articulate conditions under which “unproven” therapies may be offered to patients outside of regular clinical trials.

View Full Text